論文・著書
2022年
Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma.
Sugimoto R, Motomura K, Ooho A, Aratake Y, Ueda A, Senju T, Tanaka Y, Yada M, Tanaka K,
Kuwano A, Morita Y, Nagasawa S, Ooe M, Mutsuki T, Yoshimoto T, Yamashita N,
Nakashima M, Hioki T, Koyanagi T, Higuchi N, Nakamura T, Harada S, Tanaka M, Tada S,
Satoh T, Uchimura K, Kuniyoshi M, Nakamuta M, Kohjima M
Internal Medicine 61(21) : 3157-3164, 2022-11
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
Sugimoto R, Satoh T, Ueda A, Senju T, Tanaka Y, Yamashita S, Koyanagi T, Kurashige T,
Higuchi N, Nakamura T, Tanaka M, Azuma Y, Ohno A, Ooho A, Ooe M, Mutsuki T,
Uchimura K, Kuniyoshi M, Tada S, Aratake Y, Yoshimoto T, Yamashita N, Harada S,
Nakamuta M, Motomura K, Kohjima M
Medicine (Baltimore) 101(40) : e30871, 2022-10
慢性膵炎急性増悪に続発し、保存的治療で軽快した多発性骨壊死の1例
森田祐輔 、桒野哲史 、長澤滋裕 、田中紘介 、矢田雅佳 、増本陽秀 、本村健太
日本消化器病学会雑誌 119 : 761-767, 2022-07
切除不能肝細胞癌に対するアテゾリズマブ・ベバシズマブ併用療法によって免疫性血小板減少性紫斑病を生じた1例
桒野哲史 、田中紘介 、長澤滋裕 、森田祐輔 、矢田雅佳 、増本陽秀 、本村健太
肝臓 63（7） : 335-341, 2022-07
A case of multiple osteonecrosis caused by acute-on-chronic pancreatitis
Morita Y, Kuwano A, Nagasawa S, Tanaka K, Yada M, Masumoto A, Motomura K
Nihon Shokakibyo Gakkai Zasshi 119(8) : 761-767, 2022-06
Therapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/β-catenin signal activation
Kuwano A, Yada M, Narutomi F, Nagasawa S, Tanaka K, Kurosaka K, Ohishi Y,
Masumoto A, Motomura K
Oncology Letters 24(1) : 216, 2022-05
Hepatitis C virus eradication ameliorates the prognosis of advanced hepatocellular carcinoma treated with sorafenib
Kuwano A, Yada M, Nagasawa S, Tanaka K, Morita Y, Masumoto A, Motomura K
Journal of Viral Hepatitis 29(7) : 543-550, 2022-05
Multicentric recurrence of intraductal papillary neoplasm of bile duct after spontaneous detachment of primary tumor: A case report
Fukuya H, Kuwano A, Nagasawa S, Morita Y, Tanaka K, Yada M, Masumoto A, Motomura K
World Journal of Clinical Cases 10(3) : 1000-1007, 2022-01
Pirfenidone attenuates acetaminophen-induced liver injury via suppressing c-Jun N-terminal kinase phosphorylation
Tashiro S, Tanaka M, Goya T, Aoyagi T, Kurokawa M, Imoto K, Kuwano A, Takahashi M,
Suzuki H, Kohjima M, Kato M, Ogawa Y
Toxicol Appl Pharmacol 1 : 434, 2022-01
Serum α-fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct-acting antiviral treatment
Kuwano A, Yada M, Nagasawa S, Tanaka K, Morita Y, Motomura K, Masumoto A
Journal of Viral Hepatitis 29(1) : 35-42, 2022-01
